Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It is intended for adult smokers who are seeking to quit by alleviating nicotine withdrawal symptoms, cravings, and providing a controlled, steady delivery of nicotine through the skin to support gradual cessation.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution through reliable logistics and validated manufacturing processes.

Niquitin, a nicotine replacement therapy, is employed in the management of nicotine dependence. - Smoking cessation: helps adult smokers reduce withdrawal symptoms, cravings, and gradually discontinue tobacco use. - Tobacco dependence: supports a stepwise reduction of nicotine intake, allowing users to transition away from cigarettes with controlled dosing. - Relapse prevention: provides continued nicotine delivery to individuals who have recently quit, decreasing the likelihood of returning to smoking.

Niquitin may cause a range of adverse reactions, most of which are related to the transdermal delivery system. Common Side Effects: - Skin irritation, itching or redness at the patch site - Burning sensation on the skin where the patch is applied - Sleep disturbance, including insomnia or vivid dreams Serious or Rare Side Effects: - Allergic reaction with swelling, hives, or difficulty breathing - Severe skin rash or dermatitis extending beyond the application area - Signs of nicotine poisoning such as nausea, vomiting, rapid heartbeat, or dizziness

When using Niquitin, several precautions should be observed to ensure safe and effective therapy. - Assess nicotine dependence level: determine appropriate patch strength based on smoking habits. - Avoid use in non‑smokers or occasional smokers: unnecessary nicotine exposure can cause adverse effects. - Do not combine with other nicotine products: concurrent use may lead to excess nicotine. - Monitor cardiovascular status: patients with recent heart attack or uncontrolled hypertension should use with caution. - Keep patch away from children and pets: accidental exposure can be harmful. - Store at room temperature: keep in original packaging, protect from moisture and direct heat.

Niquitin can interact with other medicines, altering their effects or increasing risk of side effects. Major Interactions (Avoid): - Other nicotine replacement products: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive episodes. - CYP1A2 substrate drugs (e.g., theophylline): nicotine can increase their metabolism, reducing efficacy. Moderate Interactions (Monitor Closely): - Antidepressants such as SSRIs: nicotine may affect plasma levels, requiring monitoring. - Beta‑blockers: nicotine can influence heart rate and blood pressure, necessitating observation. - Insulin or oral hypoglycemics: nicotine may affect glucose control, requiring dose adjustments.